Sophia Humphreys, PharmD, MHA, BCBBS, spoke about how she views formulary management as a team approach.
Sophia Humphreys, PharmD, MHA, BCBBS, director of system pharmacy formulary management and clinical programs at Sutter Health and clinical assistant professor, University of Washington School of Pharmacy, talked about how multiple departments can work together for formulary management.
Transcript
How important is teamwork in formulary management?
So I see formulary management as a whole team approach. There's an old saying, "It takes a village"; with formulary management, you can only rely on 1 particular group. For example, when we evaluate 1 subclass of medication treatment, if you wanted to work on a new treatment for Alzheimer's disease, you have to involve your local clinical experts and your physician frontline experts, who are actually treating these patients, who are actually monitoring these patients—you would love to have their input. And in the meantime, you want to have your formulary experts, usually, they are PharmDs, they would do clinical evaluations, they will do drug information study, they will evaluate the efficacy, safety, and tolerability of these treatments. Also, we need to work with our hospital CEOs and hospital CMOs (chief medical officers), [and] our hospital DOPs, which is the director of pharmacy, to work on operations of these particular treatments. Some treatments would require different baseline labs and monitoring. Some of them require ongoing monitoring, which involves lab, involves imaging. And after all of the clinical data are evaluated, we also wanted to work with our supply chain experts to secure contracting for our patients, for our system, as well as payers, and medication informatics, and as well as finance and legal teams.
So really within each IDN (integrated delivery network), formulary management really requires a systematic and integrated approach. And in the meantime, we also work with external partners such as professional associations, foundations to support our patients, and also our drug companies sometimes offer patient assistance, and sometimes offer information that we cannot obtain from [a] published channel. Those would help our pharmacists and our physicians to evaluate the needs for the patients and to have a more comprehensive approach when we manage a complicated disease state and when we make formulary decisions.
Frameworks for Advancing Health Equity: Youth Behavioral Health Strategy Program
September 17th 2024Chris Barton, LCSW, of Horizon Blue Cross Blue Shield of New Jersey, explores how the Youth Behavioral Health Strategy program focuses on addressing the specific needs of youth with mental health and substance use issues through a comprehensive approach.
Listen
For Better Cancer Outcomes, It’s All About Access
August 21st 2025New drugs aren't the only advances in oncology. Innovation includes collaboration between to remove barriers to remove barriers to care, according to experts who gathered for a session of the Institute for Value-Based Medicine in Arlington, Virginia.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More